Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists

Tsugumi Fujita, Takeru Nose, Masahide Nakajima, Yoshihisa Inoue, Tommaso Costa, Yasuyuki Shimohigashi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

An antagonist specific for the thrombin receptor is expected to be a remedy for thrombosis. Structure-activity studies of thrombin receptor-tethered ligand SFLLRNP have revealed the importance of the Phe-2-phenyl group in receptor recognition and the replacement of the Phe-2 by para-fluorophenylalanine [(p-F)Phe] was found to enhance its activity. In order to obtain a small sized antagonist, a series of (p-F)Phe derivatives was designed and synthesized novel structural elements essential for receptor interactions being introduced at both the N and C-termini, β-Mercaptopropionyl (βMp) or its derivative activated by S-3-nitro-2-pyridinesulphenyl (Npys) was introduced at the N-terminus, and phenylmethyl amines were coupled to the C-terminus. All compounds were inactive when assayed for human platelet aggregation, indicating that they are not agonists. β-Mercaptopropionyl derivatives were also inactive as antagonists. However, Npys-containing analogs were found to inhibit the agonist activity of SFLLRNP. In particular, SNpys-βMp-(p-F)Phe-NH-R [R = -CH(C6H5)2 and -CH2-CH-(C6H5)2] potently suppressed platelet aggregation. The results suggested that (p-F)Phe can be used as a structural core to construct an effective antagonist conformation.

Original languageEnglish
Pages (from-to)174-179
Number of pages6
JournalJournal of Biochemistry
Volume126
Issue number1
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

p-Fluorophenylalanine
Thrombin Receptors
thrombin receptor peptide SFLLRNP
Amides
Derivatives
Platelets
Platelet Aggregation
Agglomeration
Amines
Conformations
Thrombosis
Ligands

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology

Cite this

Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists. / Fujita, Tsugumi; Nose, Takeru; Nakajima, Masahide; Inoue, Yoshihisa; Costa, Tommaso; Shimohigashi, Yasuyuki.

In: Journal of Biochemistry, Vol. 126, No. 1, 01.01.1999, p. 174-179.

Research output: Contribution to journalArticle

Fujita, Tsugumi ; Nose, Takeru ; Nakajima, Masahide ; Inoue, Yoshihisa ; Costa, Tommaso ; Shimohigashi, Yasuyuki. / Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists. In: Journal of Biochemistry. 1999 ; Vol. 126, No. 1. pp. 174-179.
@article{2dbb2a2fee37465197a2a428686312be,
title = "Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists",
abstract = "An antagonist specific for the thrombin receptor is expected to be a remedy for thrombosis. Structure-activity studies of thrombin receptor-tethered ligand SFLLRNP have revealed the importance of the Phe-2-phenyl group in receptor recognition and the replacement of the Phe-2 by para-fluorophenylalanine [(p-F)Phe] was found to enhance its activity. In order to obtain a small sized antagonist, a series of (p-F)Phe derivatives was designed and synthesized novel structural elements essential for receptor interactions being introduced at both the N and C-termini, β-Mercaptopropionyl (βMp) or its derivative activated by S-3-nitro-2-pyridinesulphenyl (Npys) was introduced at the N-terminus, and phenylmethyl amines were coupled to the C-terminus. All compounds were inactive when assayed for human platelet aggregation, indicating that they are not agonists. β-Mercaptopropionyl derivatives were also inactive as antagonists. However, Npys-containing analogs were found to inhibit the agonist activity of SFLLRNP. In particular, SNpys-βMp-(p-F)Phe-NH-R [R = -CH(C6H5)2 and -CH2-CH-(C6H5)2] potently suppressed platelet aggregation. The results suggested that (p-F)Phe can be used as a structural core to construct an effective antagonist conformation.",
author = "Tsugumi Fujita and Takeru Nose and Masahide Nakajima and Yoshihisa Inoue and Tommaso Costa and Yasuyuki Shimohigashi",
year = "1999",
month = "1",
day = "1",
doi = "10.1093/oxfordjournals.jbchem.a022419",
language = "English",
volume = "126",
pages = "174--179",
journal = "Journal of Biochemistry",
issn = "0021-924X",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Design and synthesis of para-fluorophenylalanine amide derivatives as thrombin receptor antagonists

AU - Fujita, Tsugumi

AU - Nose, Takeru

AU - Nakajima, Masahide

AU - Inoue, Yoshihisa

AU - Costa, Tommaso

AU - Shimohigashi, Yasuyuki

PY - 1999/1/1

Y1 - 1999/1/1

N2 - An antagonist specific for the thrombin receptor is expected to be a remedy for thrombosis. Structure-activity studies of thrombin receptor-tethered ligand SFLLRNP have revealed the importance of the Phe-2-phenyl group in receptor recognition and the replacement of the Phe-2 by para-fluorophenylalanine [(p-F)Phe] was found to enhance its activity. In order to obtain a small sized antagonist, a series of (p-F)Phe derivatives was designed and synthesized novel structural elements essential for receptor interactions being introduced at both the N and C-termini, β-Mercaptopropionyl (βMp) or its derivative activated by S-3-nitro-2-pyridinesulphenyl (Npys) was introduced at the N-terminus, and phenylmethyl amines were coupled to the C-terminus. All compounds were inactive when assayed for human platelet aggregation, indicating that they are not agonists. β-Mercaptopropionyl derivatives were also inactive as antagonists. However, Npys-containing analogs were found to inhibit the agonist activity of SFLLRNP. In particular, SNpys-βMp-(p-F)Phe-NH-R [R = -CH(C6H5)2 and -CH2-CH-(C6H5)2] potently suppressed platelet aggregation. The results suggested that (p-F)Phe can be used as a structural core to construct an effective antagonist conformation.

AB - An antagonist specific for the thrombin receptor is expected to be a remedy for thrombosis. Structure-activity studies of thrombin receptor-tethered ligand SFLLRNP have revealed the importance of the Phe-2-phenyl group in receptor recognition and the replacement of the Phe-2 by para-fluorophenylalanine [(p-F)Phe] was found to enhance its activity. In order to obtain a small sized antagonist, a series of (p-F)Phe derivatives was designed and synthesized novel structural elements essential for receptor interactions being introduced at both the N and C-termini, β-Mercaptopropionyl (βMp) or its derivative activated by S-3-nitro-2-pyridinesulphenyl (Npys) was introduced at the N-terminus, and phenylmethyl amines were coupled to the C-terminus. All compounds were inactive when assayed for human platelet aggregation, indicating that they are not agonists. β-Mercaptopropionyl derivatives were also inactive as antagonists. However, Npys-containing analogs were found to inhibit the agonist activity of SFLLRNP. In particular, SNpys-βMp-(p-F)Phe-NH-R [R = -CH(C6H5)2 and -CH2-CH-(C6H5)2] potently suppressed platelet aggregation. The results suggested that (p-F)Phe can be used as a structural core to construct an effective antagonist conformation.

UR - http://www.scopus.com/inward/record.url?scp=0032855356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032855356&partnerID=8YFLogxK

U2 - 10.1093/oxfordjournals.jbchem.a022419

DO - 10.1093/oxfordjournals.jbchem.a022419

M3 - Article

C2 - 10393336

AN - SCOPUS:0032855356

VL - 126

SP - 174

EP - 179

JO - Journal of Biochemistry

JF - Journal of Biochemistry

SN - 0021-924X

IS - 1

ER -